# Probiotics in Irritable Bowel Syndrome

> **NCT00846170** · PHASE3 · WITHDRAWN · sponsor: **Meir Medical Center**

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** co-biotic
- **DRUG:** placebo 2T/day

## Key facts

- **NCT ID:** NCT00846170
- **Lead sponsor:** Meir Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-09
- **Primary completion:** 2012-03
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** sponsor decided they are not interested in the study due to finacial reasons
- **Last updated:** 2015-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00846170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00846170, "Probiotics in Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00846170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
